MAK | Male germ cell-associated kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
GCM2 | Glial cells missing homolog 2 (Drosophila) | Disease related genes Transcription factors
| | | | | Not detected |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SMIM13 | Small integral membrane protein 13 | Predicted membrane proteins
| | | | | Expressed in all |
ERVFRD-1 | Endogenous retrovirus group FRD, member 1 | Predicted membrane proteins
| | | | | Tissue enriched |
NEDD9 | Neural precursor cell expressed, developmentally down-regulated 9 | Plasma proteins
| | | | | Expressed in all |
TMEM170B | Transmembrane protein 170B | Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
HIVEP1 | Human immunodeficiency virus type I enhancer binding protein 1 | Transcription factors
| | | | | Expressed in all |
EDN1 | Endothelin 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
PHACTR1 | Phosphatase and actin regulator 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
TBC1D7 | TBC1 domain family, member 7 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
GFOD1 | Glucose-fructose oxidoreductase domain containing 1 | | | | | | Mixed |
AL583828.1 | | | | | | | Tissue enhanced |
SIRT5 | Sirtuin 5 | FDA approved drug targets
| | | | | Expressed in all |
NOL7 | Nucleolar protein 7, 27kDa | | | | | | Expressed in all |
RANBP9 | RAN binding protein 9 | | | | | | Expressed in all |
MCUR1 | Mitochondrial calcium uniporter regulator 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
RNF182 | Ring finger protein 182 | Predicted membrane proteins
| | | | | Tissue enhanced |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
JARID2 | Jumonji, AT rich interactive domain 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
DTNBP1 | Dystrobrevin binding protein 1 | Disease related genes
| | | | | Expressed in all |
GMPR | Guanosine monophosphate reductase | Enzymes Plasma proteins
| | | | | Expressed in all |
ATXN1 | Ataxin 1 | Disease related genes
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
FAM8A1 | Family with sequence similarity 8, member A1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NUP153 | Nucleoporin 153kDa | | | | | | Expressed in all |
KIF13A | Kinesin family member 13A | | | | | | Expressed in all |
TPMT | Thiopurine S-methyltransferase | Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
KDM1B | Lysine (K)-specific demethylase 1B | | | | | | Expressed in all |
DEK | DEK oncogene | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
RNF144B | Ring finger protein 144B | Predicted membrane proteins
| | | | | Expressed in all |
ID4 | Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | Transcription factors
| | | | | Tissue enhanced |
MBOAT1 | Membrane bound O-acyltransferase domain containing 1 | Enzymes Predicted membrane proteins
| | | | | Mixed |
E2F3 | E2F transcription factor 3 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
CDKAL1 | CDK5 regulatory subunit associated protein 1-like 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
SOX4 | SRY (sex determining region Y)-box 4 | Transcription factors
| | | | | Expressed in all |
PRL | Prolactin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HDGFL1 | Hepatoma derived growth factor-like 1 | | | | | | Tissue enriched |
NRSN1 | Neurensin 1 | Predicted membrane proteins
| | | | | Tissue enriched |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
KAAG1 | Kidney associated antigen 1 | | | | | | Not detected |
MRS2 | MRS2 magnesium transporter | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
GPLD1 | Glycosylphosphatidylinositol specific phospholipase D1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
KIAA0319 | KIAA0319 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TDP2 | Tyrosyl-DNA phosphodiesterase 2 | Predicted secreted proteins
| | | | | Expressed in all |
ACOT13 | Acyl-CoA thioesterase 13 | | | | | | Expressed in all |
C6orf62 | Chromosome 6 open reading frame 62 | | | | | | Expressed in all |
GMNN | Geminin, DNA replication inhibitor | Cancer-related genes
| | | | | Expressed in all |